Tag: lymphoma

Home / lymphoma

Categories

JW Therapeutics Announces NMPA Approval of Relmacabtagene Autoleucel Injection in Patients with Relapsed or Refractory Follicular Lymphoma

SHANGHAI, CHINA, October 10, 2022 - JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing, and commercializing cell immunotherapy p...
lymphoma

Crizotinib is approved by FDA for ALK-positive inflammatory myofibroblastic tumor

 July 2022: Crizotinib (Xalkori, Pfizer Inc.) was granted approval by the Food and Drug Administration (FDA) for the treatment of adult and paediatric patients 1 year of age and older who were diagn...
lymphoma

JW Therapeutics’ IND is cleared by China NMPA for CAR T-Cell therapy in large B-Cell lymphoma

China's National Medical Products Administration (NMPA) has approved JW Therapeutics' investigational new drug (IND) application for a key clinical trial of Carteyva (relmacabtagene autoleucel) in peo...
lymphoma

Why do young people have a high incidence of lymphoma?

LymphPeople have very little knowledge of lymph. The neck, groin, and armpits are all lymph. If there is a problem with the lymphatic system, the body's toxins will be stored in the body in large quan...
lymphoma

Scan the code